Gengraf en es it fr

Gengraf Brand names, Gengraf Analogs

Gengraf Brand Names Mixture

  • No information avaliable

Gengraf Chemical_Formula


Gengraf RX_link

Gengraf fda sheet

Gengraf FDA

Gengraf msds (material safety sheet)

Gengraf Synthesis Reference

No information avaliable

Gengraf Molecular Weight


Gengraf Melting Point

No information avaliable

Gengraf H2O Solubility

No information avaliable

Gengraf State


Gengraf LogP


Gengraf Dosage Forms

Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)

Gengraf Indication

For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis

Gengraf Pharmacology

Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.

Gengraf Absorption

No information avaliable

Gengraf side effects and Toxicity

No information avaliable

Gengraf Patient Information


Gengraf Organisms Affected

Humans and other mammals